Navigate to Other Sector


Healthcare Newsletter – March 2017

Frontier MedTech Innovation from India - Meril Lifesciences sets the trend
Repurposed DrugsContinue to Offer Merit in light of Escalating Drug Development Costs
Capital Markets continue to dictate Pharma Business Models
China takes the Big Leap to Expand Healthcare Access

Sathguru Foot Print

Embracing Innovation, Driving Growth across the Healthcare Continuum-“Making in India”

Excerpts from our whitepaper released at ASSOCHAM MEDCON 2017:


  • Industry graduating from substitutable generics to specialty pharma & complex generics
  • Selective engagement in novel drug discovery & development
  • Increasing use of bioinformatics tools & predictive in-silico modeling
  • Innovation in manufacturing lags behind and calls for near term attention

Medical Devices

  • Emerging use of 3D printing
  • Increasing pursuit of drug device combinations
  • Pervasive use of robotics, AI and ML
  • Leveraging IoT to progress towards a more connected continuum of care


  • Greater emphasis on consumer convenience and digitization
  • Pursuit of PPPs as a means to bridge the infrastructure gap
  • Genomics & less invasive tests expanding possibilities in cancer care
  • More sensitive and multiplexed POC tests

Healthcare Delivery

  • Innovation in delivery models with involvement of public and private sector
  • Proliferation of startups pursuing technology led solutions

Click here to download the whitepaper

BIO 2017 (San Diego, CA – June 2017)

Look forward to meeting you at the beach or in the convention center (Booth 4700). Sathguru’s CEO Vijay is moderating a panel on biologics in crop improvement & we will have representation from our US & India healthcare advisory teams.
Stop by to say Hello to us!

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons